Compliance Law360 provides cutting-edge news and analysis of interest to corporate compliance officers and the lawyers and consultants who advise them. From real-time information and data on regulation and enforcement to incisive features on the increasing demands facing chief compliance officers in today’s world, the wire aims to be a one-stop shop for CCOs looking to stay abreast with a complex world.

Sign up for a 7-day FREE trial today!

Latest News in Compliance

• March 05, 2026

  Fintech Sues Deutsche Bank, Pathward Over Pharma Flags

  A self-described barter-based payment platform sued Deutsche Bank AG and Pathward NA, alleging it was improperly placed on an industry blacklist following the banks' assertions it was "transaction laundering" for companies selling gray-market peptides.

• March 05, 2026

  Treasury, OPM Must Face Privacy Suit Over DOGE Info Access

  The federal government must face a proposed class action accusing it of the "largest data breach" in the nation's history, after a D.C. federal judge said Wednesday that the plaintiffs alleged factual injuries suffered from the disclosure of their most sensitive information, which are "foundational to Americans' data-driven, internet-based lives."

• March 05, 2026

  DC Circ. Urged To Pause DOT Immigrant Truck Driver Rule

  Local governments, legal advocates, Teamsters California and others have urged the D.C. Circuit to suspend the U.S. Department of Transportation's new final rule containing sweeping restrictions on nondomiciled commercial driver's licenses for immigrants, saying nearly 200,000 drivers would be culled from the workforce and trigger a supply chain and critical services crisis. 

• March 05, 2026

  Wash. Lawyer Disbarred For Theft Of Client Funds, False Docs

  Washington's highest court Thursday disbarred attorney Stephen K. Monro, rejecting his argument that a Washington State Bar Association hearing officer applied the wrong standard of proof when considering evidence against him.

• March 05, 2026

  Pfizer Gets OK For $29M SEC Payout From Insider Case

  A New York federal judge on Thursday approved a request from the U.S. Securities and Exchange Commission and Pfizer to have $29 million paid out to a Pfizer subsidiary from the roughly $75.2 million distribution left over from a $602 million insider trading deal.

See more Compliance news